DNA Methylation subclass Receptor Tyrosine Kinase II (RTK II) is predictive for seizure development in glioblastoma patients
Ontology highlight
ABSTRACT: DNA Methylation subclass Receptor Tyrosine Kinase II (RTK II) is predictive for seizure development in glioblastoma patients
PROVIDER: PRJNA779400 | ENA |
REPOSITORIES: ENA
ACCESS DATA